Clinical Trial Update: Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating hybrid molecular imaging of estrogen receptor in breast cancer patients with ductal carcinoma in situ; the trial completed and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ductal Carcinoma in Situ

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Breast Cancer, Ductal Carcinoma in Situ - Category | Phase 2 | Status: COMPLETED | Results posted: 2025-02-12